KIF2A expression was elevated in AML patients [2.480 (1.232-3.809)] compared to healthy controls [1.162 (0.515-1.878)] (P<0.001) (Figure 1A), and ROC curve showed that KIF2A expression was able to distinguish AML patients from healthy controls with AUC of 0.793 (95%CI: 0.724-0.826) (Figure 1B). The gene discussed is KIF2A; the disease is acute myeloid leukemia.